BRONCHITIS AND HOMEOPATHY

Similar lung inflammation happened in SARS patients during the 2003 outbreak, mainly in China. It is hypothesised that Actmera may have potential against cytokine release in COVID-19 as an inhibitor of the interleukin-6 (IL-6) receptor. ................
................